You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BGLC Award Disclosure
Tan Lee Su-leng · SEC Form 4 · Filed Aug 14, 2026
Award
Reported value range
Not reported
Tan Lee Su-leng Chief Executive Officer
BGLC
Transaction date
Aug 13, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 1 day later
BGLC daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 338,709 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001520138-26-000349
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bionexus Gene Lab Corp BGLC Current | Award | Aug 13, 2026 | Not reported |